NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $93 | -100.0% | 1,280 | -86.0% | 0.00% | -100.0% |
| Q3 2022 | $693,000 | +9.3% | 9,126 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $634,000 | -34.6% | 9,126 | -22.1% | 0.00% | -40.0% |
| Q1 2022 | $970,000 | +11.0% | 11,716 | +0.6% | 0.01% | +25.0% |
| Q4 2021 | $874,000 | -23.8% | 11,646 | +17.9% | 0.00% | -33.3% |
| Q3 2021 | $1,147,000 | +315.6% | 9,875 | +689.4% | 0.01% | +200.0% |
| Q2 2021 | $276,000 | +117.3% | 1,251 | +29.5% | 0.00% | +100.0% |
| Q1 2021 | $127,000 | -24.9% | 966 | -1.2% | 0.00% | 0.0% |
| Q4 2020 | $169,000 | +428.1% | 978 | +239.6% | 0.00% | – |
| Q3 2020 | $32,000 | +88.2% | 288 | 0.0% | 0.00% | – |
| Q2 2020 | $17,000 | -10.5% | 288 | 0.0% | 0.00% | – |
| Q1 2020 | $19,000 | – | 288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |